My Profile e-Learning Center my.ASTHO Contact Us

All COVID-19 Resources

Filter Results

Clear All Filters

COVID-19

Published Date

Displaying 4 results for

GO
Search Filters: COVID Vaccine cancel Marcus Plescia cancel

Maximizing the Benefit of COVID-19 Therapeutics: Considerations for State Public Health Officials

Brief,
Infectious Disease,
COVID-19,
COVID and Communication,
COVID and Community Mitigation,
COVID and Funding,
COVID and Health Equity/Health Disparities,
COVID and Healthcare Systems,
COVID Recovery,
COVID Resilience,
COVID Vaccine,
COVID and Workforce,
Preparedness,
Health Equity,
Alaska,
Connecticut,
Minnesota,
Mississippi,
Oregon,
Partnership,
Marcus Plescia,
Jessica Baggett,
Katie Greene,
Katie Huber,
Matt D’Ambrosio,
Andrea Thoumi,
Mark McClellan

An issue brief by ASTHO and the Duke University Margolis Center for Health Policy that highlights considerations for state health officials as they look to maximize the benefits of COVID-19 therapeutics.

The Historic Opportunity COVID-19 Presents to Address Health Equity

Health Equity,
Infectious Disease,
COVID-19,
COVID Testing and Screening,
COVID Vaccine,
COVID and Health Equity/Health Disparities,
COVID Preparedness,
COVID Recovery,
COVID Resilience,
COVID and Workforce,
Population Health and Prevention,
Race and Public Health,
Rural Health,
Social Determinants of Health,
At-Risk Populations,
Preparedness,
Pandemics,
Advocacy,
Blog,
Marcus Plescia,
Operationalizing Equity,
People of Public Health,
Series,
Chief Medical Officer Series

The disparities experienced during the COVID pandemic have brought a national focus to health equity in our nation. The attention and resources currently being provided to help address health inequities provide an opportunity that I have ...

Vaccinating Children: The Final Step

Infectious Disease,
COVID-19,
COVID Vaccine,
COVID and Special Populations,
Immunization,
Vaccine Distribution,
Population Health and Prevention,
Healthcare Access,
Social and Behavioral Health,
Women, Infant, and Family Health,
Partnership,
Blog,
Claire Hannan,
Marcus Plescia,
Infant and Child Health

As we anticipate the likely approval of COVID-19 vaccination for children, our nation faces the final step to bring the COVID-19 pandemic under control. If approved for children ages 5-11, the COVID-19 vaccine will dramatically improve our ...